救济治疗和NeuroX合并,创建了MindMaze治疗疗法,重点是神经紊乱的数字治疗。 Relief Therapeutics and NeuroX merged to create MindMaze Therapeutics, focusing on digital treatments for neurological disorders.

救济治疗公司和NeuroX公司完成了组建MindMaze治疗公司的业务组合,这是一家侧重于开发神经紊乱新疗法的新公司。 Relief Therapeutics and NeuroX have completed a business combination to form MindMaze Therapeutics, a new company focused on developing innovative treatments for neurological disorders. 新成立的实体旨在通过利用两个组织的综合专门知识和资源,推进数字治疗和神经技术解决方案。 The newly formed entity aims to advance digital therapeutics and neurotechnology solutions, leveraging the combined expertise and resources of both organizations. 这一举动标志着公司对加速开发大脑健康技术的重视发生了战略转变。 The move marks a strategic shift in the companies' focus toward accelerating the development of brain health technologies.